DelveInsight’s “Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Knee Osteoarthritis, historical and forecasted epidemiology as well as the Knee Osteoarthritis market trends in the United States, EU4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan.
Discover which therapies are expected to grab the Knee Osteoarthritis Market Share @ Knee Osteoarthritis Market Outlook
Key Takeaways from the Knee Osteoarthritis Market Report
- The Knee Osteoarthritis market size in the 7MM was around USD 14,400 million in 2023.
- Knee Osteoarthritis is more prevalent in females than males, accounting for nearly 60% and 40% cases respectively.
- Among the severity-specific cases, the cases of mild-severity accounted for the highest number in the 7MM.
- There is currently no standard lab test to verify the presence of Knee Osteoarthritis.
- In May , Organogenesis announced positive topline data from the Phase III randomized control trial evaluating the safety and efficacy of ReNu for the management of knee osteoarthritis symptoms.
- Currently, the drugs used for the Knee Osteoarthritis treatment include NSAIDs, Opioids, Intra Articular-Corticosteroids, Intra Articular-Hyaluronic acid and others.
- Expected launch of potential Knee Osteoarthritis therapies by key Knee Osteoarthritis companies like Taiwan Liposome Company (TLC599), Centrexion Therapeutics (CNTX-4975), Biosplice Therapeutics (Lorecivivint), and others may increase the market size in the coming years, assisted by an increase in the Knee Osteoarthritis prevalent population.
Stay ahead in the Knee Osteoarthritis Therapeutics Market with DelveInsight’s Strategic Report @ Knee Osteoarthritis Market
Knee Osteoarthritis Epidemiology Segmentation in the 7MM
The epidemiology section of Knee Osteoarthritis offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Knee Osteoarthritis Epidemiology trends @ Knee Osteoarthritis Prevalence
Knee Osteoarthritis Drugs Market
The Knee Osteoarthritis Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Knee Osteoarthritis signaling in Knee Osteoarthritis are likely to uncover new therapeutic targets and further expand treatment options for patients.
Knee Osteoarthritis Treatment Market Landscape
The Knee Osteoarthritis treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Knee Osteoarthritis has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Knee Osteoarthritis treatment guidelines, visit @ Knee Osteoarthritis Treatment Market Landscape
Knee Osteoarthritis Market Outlook
The report’s outlook on the Knee Osteoarthritis market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Knee Osteoarthritis therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Knee Osteoarthritis drug and late-stage pipeline therapy.
Knee Osteoarthritis Drugs Uptake
The drug chapter of the Knee Osteoarthritis report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Knee Osteoarthritis.
Major Knee Osteoarthritis Companies
Anika Therapeutics, Sanofi, Bioventus, Genzyme, Taiwan Liposome Company, Centrexion Therapeutics, Biosplice Therapeutics, Noven Pharmaceuticals, Kolon TissueGene, and others.
Learn more about the FDA-approved drugs for Knee Osteoarthritis @ Drugs for Knee Osteoarthritis Treatment
Scope of the Knee Osteoarthritis Market Report
- Coverage- 7MM
- Study Period- 2020-2034
- Knee Osteoarthritis Companies- Anika Therapeutics, Sanofi, Bioventus, Genzyme, Taiwan Liposome Company, Centrexion Therapeutics, Biosplice Therapeutics, Noven Pharmaceuticals, Kolon TissueGene, and others.
- Knee Osteoarthritis Therapies- CINGAL, DUROLANE, GELSYN-3, ZILRETTA, SYNVISC-ONE, TLC599, CNTX-4975, Lorecivivint, and others.
- Knee Osteoarthritis Market Dynamics: Knee Osteoarthritis Market Drivers and Barriers
- Knee Osteoarthritis Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Knee Osteoarthritis Drugs in development @ Knee Osteoarthritis Clinical Trials Assessment
Table of Contents
- Key Insights
- Report Introduction
- Executive Summary
- Key Events
- Epidemiology and Market Methodology
- Knee Osteoarthritis (OA) Market Overview at a Glance
- Disease Background and Overview
- Treatment and Management of Knee Osteoarthritis
- Treatment Guidelines
- Epidemiology and Patient Population in the 7MM
- Patient Journey
- Marketed Drugs
- Emerging Drugs
- Knee Osteoarthritis (OA): 7MM Analysis
- Unmet Needs
- SWOT Analysis
- KOL Views
- Market Access and Reimbursement
- Appendix
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
